 And she's also founder and chair of the Women in Medicine Summit. After the break, we'll get an explanation of prior authorization. With some cancer drugs costing hundreds of thousands of dollars, it isn't surprising that insurance companies want to be cautious about approving them. Unfortunately, sometimes they just seem to be throwing up roadblocks.